Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

计划入组 30 人 · 首次发布于 2023 年 4 月 5 日

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

计划入组 140 人 · 首次发布于 2009 年 2 月 3 日

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

计划入组 34 人 · 首次发布于 2019 年 4 月 1 日

MK-8583 (Merck Sharp & Dohme)

MK-0782 (Merck Sharp & Dohme)

MK-0831 (Merck Sharp & Dohme)

Merck Sharp & Dohme Corp

Chile

Merck Sharp & Dohme BV

Netherlands

Merck Sharp & Dohme Corp.

United States

Enfortumab Vedotin and Pembrolizumab Show Significant Survival Benefit in Urothelial Cancer Treatment

Neoadjuvant Pembrolizumab Improves Event-Free Survival in Advanced Melanoma Patients

LEAP-012 Trial: Lenvatinib, Pembrolizumab, and TACE Improve PFS in Intermediate-Stage HCC